Suppr超能文献

相似文献

1
Intratumoral patterns of genomic imbalance in glioblastomas.
Brain Pathol. 2010 Sep;20(5):936-44. doi: 10.1111/j.1750-3639.2010.00395.x. Epub 2010 Mar 18.
2
Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components.
Genes Chromosomes Cancer. 2002 Aug;34(4):416-27. doi: 10.1002/gcc.10087.
7
Amplification of the PDGFRA, KIT and KDR genes in glioblastoma: a population-based study.
Neuropathology. 2011 Dec;31(6):583-8. doi: 10.1111/j.1440-1789.2011.01204.x. Epub 2011 Mar 7.
8
Primary glioblastomas with and without EGFR amplification: relationship to genetic alterations and clinicopathological features.
Neuropathology. 2010 Aug;30(4):392-400. doi: 10.1111/j.1440-1789.2009.01081.x. Epub 2009 Dec 16.
10
Chromosome DNA imbalances in human astrocytic tumors: a comparative genomic hybridization study of 63 Chinese patients.
Pathol Res Pract. 2010 Oct 15;206(10):674-81. doi: 10.1016/j.prp.2010.05.012. Epub 2010 Jun 29.

引用本文的文献

2
Gliosarcoma: A Multi-Institutional Analysis on Clinical Outcomes and Prognostic Factors.
Cancer Med. 2024 Nov;13(22):e70347. doi: 10.1002/cam4.70347.
3
Neuronal differentiation drives the antitumor activity of mitogen-activated protein kinase kinase (MEK) inhibition in glioblastoma.
Neurooncol Adv. 2023 Oct 12;5(1):vdad132. doi: 10.1093/noajnl/vdad132. eCollection 2023 Jan-Dec.
6
Molecular targeted therapy: A new avenue in glioblastoma treatment.
Oncol Lett. 2022 Dec 15;25(2):46. doi: 10.3892/ol.2022.13632. eCollection 2023 Feb.
7
Cancer cell heterogeneity & plasticity in glioblastoma and brain tumors.
Semin Cancer Biol. 2022 Jul;82:162-175. doi: 10.1016/j.semcancer.2021.02.014. Epub 2021 Feb 25.
8
Molecular Features and Prognostic Factors of Pleomorphic Xanthoastrocytoma: A Collaborative Investigation of the Tohoku Brain Tumor Study Group.
Neurol Med Chir (Tokyo). 2020 Nov 15;60(11):543-552. doi: 10.2176/nmc.oa.2020-0155. Epub 2020 Oct 16.
9
Characterization and prognostic significance of alternative splicing events in lower-grade diffuse gliomas.
J Cell Mol Med. 2020 Nov;24(22):13171-13180. doi: 10.1111/jcmm.15924. Epub 2020 Oct 2.
10
Clinical characterization, genetic profiling, and immune infiltration of TOX in diffuse gliomas.
J Transl Med. 2020 Aug 6;18(1):305. doi: 10.1186/s12967-020-02460-3.

本文引用的文献

1
IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.
Clin Cancer Res. 2009 Oct 1;15(19):6002-7. doi: 10.1158/1078-0432.CCR-09-0715. Epub 2009 Sep 15.
2
Genetic alterations and signaling pathways in the evolution of gliomas.
Cancer Sci. 2009 Dec;100(12):2235-41. doi: 10.1111/j.1349-7006.2009.01308.x. Epub 2009 Aug 6.
3
MicroRNAs in Cancer.
Annu Rev Med. 2009;60:167-79. doi: 10.1146/annurev.med.59.053006.104707.
4
IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas.
Am J Pathol. 2009 Apr;174(4):1149-53. doi: 10.2353/ajpath.2009.080958. Epub 2009 Feb 26.
6
Comprehensive genomic characterization defines human glioblastoma genes and core pathways.
Nature. 2008 Oct 23;455(7216):1061-8. doi: 10.1038/nature07385. Epub 2008 Sep 4.
7
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses.
Science. 2008 Sep 26;321(5897):1801-6. doi: 10.1126/science.1164368. Epub 2008 Sep 4.
8
An integrated genomic analysis of human glioblastoma multiforme.
Science. 2008 Sep 26;321(5897):1807-12. doi: 10.1126/science.1164382. Epub 2008 Sep 4.
9
The genomic landscapes of human breast and colorectal cancers.
Science. 2007 Nov 16;318(5853):1108-13. doi: 10.1126/science.1145720. Epub 2007 Oct 11.
10
The 2007 WHO classification of tumours of the central nervous system.
Acta Neuropathol. 2007 Aug;114(2):97-109. doi: 10.1007/s00401-007-0243-4. Epub 2007 Jul 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验